MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIAL

PURPOSE: To evaluate prognostic factors and impact of participation in a randomized trial in non-metastatic medulloblastoma. METHODS AND PATIENTS: 382 patients with non-metastatic medulloblastoma aged 4–21 years with primary neurosurgical resections between 2001 and 2011 were enrolled into the HIT 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietzsch, Stefan, Placzek, Felix, Pietschmann, Klaus, von Bueren, André O, Matuschek, Christiane, Glück, Albrecht, Guckenberger, Matthias, Budach, Volker, Welzel, Jutta, Pöttgen, Christoph, Schmidberger, Heinz, Heinzelmann, Frank, Paulsen, Frank, Pazos, Montserrat, Schwarz, Rudolf, Hornung, Dagmar, Martini, Carmen, Grosu, Anca Ligia, Meyer, Frank Michael, Jablonska, Karolina, Dunst, Juergen, Kapp, Karin S, Dieckmann, Karin, Timmermann, Beate, Pietsch, Torsten, Warmuth-Metz, Monika, Kwiecien, Robert, Benesch, Martin, Gerber, Nicolas U, Pfister, Stefan M, Clifford, Steven C, von Hoff, Katja, Klagges, Sabine, Rutkowski, Stefan, Kortmann, Rolf-Dieter, Mynarek, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715814/
http://dx.doi.org/10.1093/neuonc/noaa222.487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715814/
http://dx.doi.org/10.1093/neuonc/noaa222.487

Ejemplares similares